ACLARION, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
ACLARION, INC. (ACON) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $102.12 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $102.12K, a 260.07% increase year-over-year.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $4.69K, a 91.60% decline year-over-year.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $16.75K, a 77.58% decline year-over-year.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $28.36K, a 59.66% decline year-over-year.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $105.37K, a 63.34% decline from fiscal 2024.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $287.45K, a 36.96% decline from fiscal 2023.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $456.00K, a 61.57% decline from fiscal 2022.
- ACLARION, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.19M, a 568.58% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $102.12K 10-Q · filed 2026-08-06 | $106.81K derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $4.69K 10-Q · filed 2026-08-06 | ||||
| 2025-12-31 | $105.37K 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $16.75K 10-Q · filed 2025-11-12 | $45.11K derived: sum of 2 quarters · filed 2026-08-06 | $101.00K derived: sum of 3 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $28.36K 10-Q · filed 2026-08-06 | $84.26K derived: sum of 2 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $55.90K 10-Q · filed 2026-08-06 | ||||
| 2024-12-31 | $287.45K 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $74.71K 10-Q · filed 2025-11-12 | $145.01K derived: sum of 2 quarters · filed 2025-11-12 | $230.84K derived: sum of 3 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $70.31K 10-Q · filed 2025-11-12 | $156.13K derived: sum of 2 quarters · filed 2025-11-12 | |||
| 2024-03-31 | $85.83K 10-Q · filed 2025-11-12 | ||||
| 2023-12-31 | $456.00K 10-K · filed 2025-04-09 | ||||
| 2023-09-30 | $137.31K 10-Q · filed 2024-11-14 | $273.94K derived: sum of 2 quarters · filed 2024-11-14 | $356.47K derived: sum of 3 quarters · filed 2024-11-14 | $492.30K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $136.63K 10-Q · filed 2024-11-14 | $219.16K derived: sum of 2 quarters · filed 2024-11-14 | $354.99K derived: sum of 3 quarters · filed 2024-11-14 | $681.19K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-03-31 | $82.53K 10-Q · filed 2024-11-14 | $218.36K derived: sum of 2 quarters · filed 2024-11-14 | $544.56K derived: sum of 3 quarters · filed 2024-11-14 | $1.25M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2022-12-31 | $135.83K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $462.03K derived: sum of 2 quarters · filed 2024-03-28 | $1.16M derived: sum of 3 quarters · filed 2024-03-28 | $1.19M 10-K · filed 2024-03-28 | $1.13M 10-K · filed 2023-02-27 |
| 2022-09-30 | $326.20K 10-Q · filed 2023-11-14 | $1.03M derived: sum of 2 quarters · filed 2023-11-14 | $1.05M 10-Q · filed 2022-11-14 | $1.13M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $701.50K 10-Q · filed 2023-11-14 | $724.63K derived: sum of 2 quarters · filed 2023-11-14 | $808.64K derived: sum of 3 quarters · filed 2023-11-14 | ||
| 2022-03-31 | $23.12K 10-Q · filed 2023-11-14 | $107.14K derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2021-12-31 | $84.01K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $177.49K 10-K/A · filed 2023-06-12 | |||
| 2021-09-30 | $93.48K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |